HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

220 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2021.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 89,846,972 shares of 183,255,226 outstanding shares and own 49% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (12,648,894 shares), VANGUARD GROUP INC (8,491,216 shares), BlackRock Inc. (7,137,310 shares), BAKER BROS. ADVISORS LP (5,994,704 shares), WELLINGTON MANAGEMENT GROUP LLP (5,847,348 shares), ArrowMark Colorado Holdings LLC (5,631,016 shares), STATE STREET CORP (4,584,299 shares), Clearbridge Investments, LLC (3,436,925 shares), JPMORGAN CHASE & CO (3,273,121 shares), and UBS OCONNOR LLC (2,325,000 shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.